Science
Mechanism of Action
Targets melanogenesis through multiple pathways: inhibits tyrosinase enzyme activity to reduce melanin production, blocks melanosome transfer from melanocytes to keratinocytes, and suppresses Stem Cell Factor (SCF) synthesis which contributes to photoinduced pigmentation. Additionally provides antioxidant protection via phenolic compounds.
Research
Clinical Evidence
Medium confidence3%
Key findings
- 01 28-day human study (n=10) at 3% concentration demonstrated significant age spot lightening and overall skin brightening with twice-daily application
- 02 In-vitro melanocyte testing showed 36% reduction in melanin content within 24 hours of exposure
Transparency
Dusting Analysis
Clinical efficacy demonstrated at 3% concentration suggests meaningful inclusion levels are required. Concentrations below 1% likely provide minimal brightening benefits.
The Formula
Formulation
Stability
Maintains high stability in aqueous formulations within pH 4.0-7.0 range. Protein components may denature below pH 3.0. Store in cool, dark conditions to prevent phenolic compound oxidation.
Conflicts
- strong oxidizing agents
- highly acidic formulations (pH < 3.0)
Safety
Safety Profile
Brassica napus derivatives have GRAS status and EU CosIng approval for cosmetic use as skin conditioning agents. No specific CIR review available for stem extract variant.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Well-researched brightening ingredient with demonstrated clinical efficacy at 3% concentration and excellent skin compatibility across all types.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources